SCHEMBL48868

SCHEMBL48868

CN(C)C(=Nc1ccncc1)N(C)C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLG P00747 1/20 0.52
NOS1 P29475 4/20 0.44
NOS3 P29474 3/20 0.44
NOS2 P35228 3/20 0.44
CHRM5 P08912 1/20 0.41
CHKA P35790 1/20 0.41
MAPT P10636 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
ADRA2A P08913 2/20 0.33
ADRA2B P18089 2/20 0.33
ADRA2C P18825 2/20 0.33
HTT P42858 1/20 0.33
POLB P06746 1/20 0.33
KMT2A Q03164 2/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
NPC1 O15118 1/20 0.32
ALOX15 P16050 1/20 0.32
CASP1 P29466 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5935352 0.83 ADRA2A (0.44) NOS1NOS3NOS2MAPTADRA2A
SCHEMBL664694 0.76 NOS1 (0.52) NOS1NOS3NOS2MAPTKMT2A
SCHEMBL10533424 0.74 HTR3E (0.54) NOS1NOS3NOS2MAPTSMN1; SMN2
SCHEMBL27981470 0.73 NOS1 (0.56) NOS1NOS3NOS2ADRA2AADRA2B
SCHEMBL27981468 0.73 HTR3E (0.52) NOS1NOS3NOS2ADRA2AADRA2B
SCHEMBL19063477 0.73 NOS1 (0.56) NOS1NOS3NOS2MAPTSMN1; SMN2
SCHEMBL4008657 0.72 CHRM5 (0.46) PLGCHRM5CHKAMAPTSMN1; SMN2
SCHEMBL4008655 0.72 CHRM5 (0.46) PLGCHRM5CHKAMAPTSMN1; SMN2
SCHEMBL13967865 0.72 NOS1 (0.33) NOS1ADRA2AADRA2BADRA2C
SCHEMBL5748747 0.71 ADRA2A (0.54) NOS1NOS3NOS2ADRA2AADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129136-B2 Kit for performing an assay CYANAGEN SRL (IT) 2012-03-06 US claimed
EP-1962095-B1 Method for increasing light emission from a chemiluminescent reaction CYANAGEN SRL (IT) 2011-06-15 EP claimed
US-20110053200-A1 Method for increasing light emission from a chemiluminescent reaction CYANAGEN SRL (IT) 2011-03-03 US claimed
US-7803573-B2 Method for increasing light emission from a chemiluminescent reaction CYANAGEN SRL (IT) 2010-09-28 US claimed
US-20080241868-A1 Method for increasing light emission from a chemiluminescent reaction CYANAGEN SRL (IT) 2008-10-02 US claimed
EP-1962095-A1 Method for increasing light emission from a chemiluminescent reaction Cyanagen Srl (IT) 2008-08-27 EP claimed
EP-0287340-B1 NOVEL ACYLATION PROCESS FOR THE SYNTHESIS OF HMG-COA REDUCTASE INHIBITORS MERCK & CO. INC. (US) 1993-09-29 EP claimed
US-4845237-A ANTIHYPERCHOLESTEROLEMIC COMPOUNDS MERCK & CO., INC. (US) 1989-07-04 US claimed
EP-0287340-A2 Novel acylation process for the synthesis of HMG-COA reductase inhibitors MERCK & CO. INC. (US) 1988-10-19 EP claimed
US-8129136-B2 Kit for performing an assay CYANAGEN SRL (IT) 2012-03-06 US disclosed
US-8088923-B2 Cyclic-fused beta-lactones and their synthesis THE TEXAS A&M UNIVERSITY SYSTEM (US) 2012-01-03 US disclosed
EP-1962095-B1 Method for increasing light emission from a chemiluminescent reaction CYANAGEN SRL (IT) 2011-06-15 EP disclosed
US-20110053200-A1 Method for increasing light emission from a chemiluminescent reaction CYANAGEN SRL (IT) 2011-03-03 US disclosed
US-7803573-B2 Method for increasing light emission from a chemiluminescent reaction CYANAGEN SRL (IT) 2010-09-28 US disclosed
US-20080241868-A1 Method for increasing light emission from a chemiluminescent reaction CYANAGEN SRL (IT) 2008-10-02 US disclosed
EP-1962095-A1 Method for increasing light emission from a chemiluminescent reaction Cyanagen Srl (IT) 2008-08-27 EP disclosed
EP-0287340-B1 NOVEL ACYLATION PROCESS FOR THE SYNTHESIS OF HMG-COA REDUCTASE INHIBITORS MERCK & CO. INC. (US) 1993-09-29 EP disclosed
US-4845237-A ANTIHYPERCHOLESTEROLEMIC COMPOUNDS MERCK & CO., INC. (US) 1989-07-04 US disclosed
EP-0287340-A2 Novel acylation process for the synthesis of HMG-COA reductase inhibitors MERCK & CO. INC. (US) 1988-10-19 EP disclosed